ReviewDrugs2021

Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review.

Laura P B Elbers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.